Abbott

News

Why non-diabetics using CGM may not be a good idea

A clinical trial has found that a continuous glucose monitor device systemically overestimated blood glucose levels when used by non-diabetic people.

News

NICE backs two AIs for remote heart failure monitoring

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biot

News

FDA clears RHYTHM AI's new algorithm for atrial fibrillation

UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation (AFib) that will be r

News

Abbott’s OTC glucose monitor ‘will grow the market’

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its

News

Digital programme improves metabolic health in diabetes

A comprehensive digital approach to helping patients manage type 2 diabetes, combining continuous glucose monitoring (CGM) devices, wearables and a mobile app, has been sh

News